On September 8, 2020 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX in North America, reported that Joseph Truitt, Chief Executive Officer, will present at the H.C. Wainwright Virtual Healthcare Conference on Monday, September 14, 2020 at 3:00 p.m. ET (Press release, BioSpecifics Technologies, SEP 8, 2020, View Source [SID1234564757]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentations may be accessed by visiting the Events and Presentations section of the BioSpecifics website at View Source An archived replay of the webcast will be available on the Company’s website for approximately 90 days following the presentation.